BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20128960)

  • 1. [Expression and subcellular localization of APOBEC3G in peripheral blood mononuclear cells and liver tissues of chronic HBV patients].
    Chen H; Wang LW; Chu XG; Yan SN; Gong ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):5-8. PubMed ID: 20128960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
    Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
    Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
    Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subcellular localization of APOBEC3G by confocal laser scanning microscope (CLSM)].
    Yang YS; Li L; Li ZL; Zeng Y
    Bing Du Xue Bao; 2007 Jan; 23(1):16-21. PubMed ID: 17886715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation.
    Pang X; Li X; Mo Z; Huang J; Deng H; Lei Z; Zheng X; Feng Z; Xie D; Gao Z
    BMC Gastroenterol; 2018 May; 18(1):61. PubMed ID: 29743020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
    Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
    J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry.
    Mous K; Jennes W; De Roo A; Pintelon I; Kestens L; Van Ostade X
    J Immunol Methods; 2011 Sep; 372(1-2):52-64. PubMed ID: 21784078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].
    Fan HB; Guo YB; Wang BJ; Zhu YF; Wu AH; Hou JL; Yang DL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):979-81. PubMed ID: 18583243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
    Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
    J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo.
    Chen H; Wang LW; Huang YQ; Gong ZJ
    Int J Mol Sci; 2010 Sep; 11(9):3501-12. PubMed ID: 20957108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between APOBEC3G polymorphisms and susceptibility to chronic hepatitis B].
    You Z; Zhou F; Wang X; Chen C; Zhou J; Zhao D; Hu G
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):769-71. PubMed ID: 23689004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B.
    Song ZW; Ma YX; Fu BQ; Teng X; Chen SJ; Xu WZ; Gu HX;
    J Microbiol; 2014 Jun; 52(6):510-4. PubMed ID: 24871977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The associations between polymorphisms of APOBEC3G and different outcomes of persistent HBV infection].
    Tian D; Zeng Z; Tian GB; Cui JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):481-6. PubMed ID: 18647522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma sB7-H3 serves as an assistant diagnostic marker for hepatitis B virus-associated hepatocellular carcinoma].
    Xu W; Li F; Yu L; Liu J; He X; Fan R; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):744-7. PubMed ID: 25001942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3G exerts tumor suppressive effects in human hepatocellular carcinoma.
    Chang LC; Kuo TY; Liu CW; Chen YS; Lin HH; Wu PF
    Anticancer Drugs; 2014 Apr; 25(4):456-61. PubMed ID: 24500029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.
    Vivekanandan P; Kannangai R; Ray SC; Thomas DL; Torbenson M
    Clin Infect Dis; 2008 Apr; 46(8):1227-36. PubMed ID: 18444860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.